Medical Probiotics Market Size is valued at USD 39.32 Bn in 2022 and is predicted to reach USD 64.13 Bn by the year 2031 at a 5.76% CAGR during the forecast period for 2023-2031.
Probiotics are "live microorganisms" that can improve health in various ways. They are beneficial to digestion because they promote gut health. To get your probiotics, try some yoghurt. The market for probiotics is growing due to rising health consciousness among consumers, increased knowledge about the benefits of probiotics, an ageing population, and the prevalence of digestive problems. Increases in meat consumption in developing countries also drive growth in the feed probiotics industry. Besides aiding digestion, probiotics have numerous additional health benefits, including improving immunity, maintaining gut health, managing weight, lowering obesity, and many more. More and more people are realizing the advantages should drive demand higher. As health concerns continue to gain prominence and as the vegan movement expands, demand for plant-based products is expected to increase. Furthermore, more and more supplements targeting inflammatory skin conditions like eczema and atopic dermatitis are being made with the help of probiotics. The expansion of the probiotics industry can be attributed to all of these factors.
However, the market growth is hampered by the strict regulatory criteria for the safety and health of the medical probiotics market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity medical probiotics because probiotics are living bacteria their cultivation and secretion are essential to the production of any product containing probiotics. Production of a given batch is likely to be hampered by the possibility of contamination from microorganisms that aren't wanted and have a high toxicity level. Additionally, the significant expenditure needed for bacterial strain research and development is anticipated to restrict market expansion further. As a result of COVID-19's unexpected impact, there has been a rise in the demand for products that boost immune health, which is good news for the probiotics industry. Many new products are being introduced because of these causes to keep up with the rising demand.
Competitive Landscape
Some Major Key Players In The Medical Probiotics Market:
- Probi AB
- Abbott
- Lonza
- Hansen Holding A/S
- Danone S.A.
- Yakult Honsha Co., Ltd.
- Nestle S.A.
- DowDuPont Inc.
- Kerry Group plc.
- BioGaia AB
- DSM
- Sun Genomics
- Evonik
- Probiotics International Limited (Protexin)
- UAS Laboratories Llc.
- Lallemand
- Glac Biotech
- Ab-Biotics
- Winclove Probiotics
- Sacco System
- General Mills Inc.
- ADM
- Unique Biotech Ltd
- Lifeway Foods, Inc.
- Suja Life, Llc
- Biohm Health
- Others
Market Segmentation:
The medical probiotics market is segmented based on ingredient type, application and distribution channel. As per the ingredient type, the market is segmented into bacteria, yeast, spore formers, and others. The bacteria segment is again sub-divided into lactobacilli, Bifidobacterium, streptococcus and bacillus. By application, the market is segmented into probiotic food & beverages, probiotic dietary supplements, probiotics for women's health, infant formula, and others. The food and beverages segment includes dairy products, non-dairy beverages, cereals, baked goods and fermented meat products. The distribution channel segment is segmented into hypermarkets/supermarkets, pharmacies/drugstores, speciality stores, and online sales.
Based On The Ingredient Type, The Yeast Segment Is Accounted As A Major Contributor To The Medical Probiotics Market.
The yeast medical probiotics market is expected to lead with a major global market share in 2022. The yeast used in making probiotic beverages is Saccharomyces boulardii. It aids in maintaining normal intestinal function and ward off microorganisms that can cause injury to the intestinal lining. It maintains a healthy intestinal barrier and modulates additional immune system components. The increased awareness regarding the benefits linked with the intake of these items is predicted to push product sales positively.
Food & Beverages Segment To Witness Growth At A Rapid Rate.
The food & beverages industry makes up the bulk of medical probiotics because some foods and drinks have entered the mainstream diet. After all, evidence suggests they provide health benefits beyond those often attributed to their nutritional content. One of the most popular eating trends of the present is the regular use of functional foods and drinks. Natural and healthful food items are becoming more mainstream, boosting sales, especially in countries like the US, Germany, the U.K., China, and India.
In The Region, The North American Medical Probiotics Market Holds A Significant Revenue Share.
The North American medical probiotics market is expected to register the maximum market share in revenue in the near future. It can be attributed to the growing interest in preventative medicine, the continued prevalence of lifestyle-related diseases, including obesity and diabetes, and the introduction of probiotic functional foods. In addition, Asia Pacific is estimated to grow rapidly in the global medical probiotics market because of the rising popularity of probiotic-containing foods and medicines.
Recent Developments:
- In Oct 2023, Nestlé released a novel combination of a probiotic strain and six different human milk oligosaccharides (HMOs) in their latest infant nutrition product. This blend aims to provide comprehensive support for the growth and development of infants as they progress through different stages of life.
- In July 2023, Danone's latest probiotic supplement, Almimama, was introduced in Spain. A clinical study revealed that the supplement helps bolster breastfeeding by diminishing the occurrence of mastitis. Danone has utilized its knowledge in breastmilk investigation and lactation to create Almimama.
Medical Probiotics Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 39.32 Bn |
|
Revenue Forecast In 2031 |
USD 64.13 Bn |
|
Growth Rate CAGR |
CAGR of 5.76% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Ingredient Type, By Application, By Distribution Channel |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Probi AB, Abbott, Lonza, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc., BioGaia AB, DSM, Sun Genomics, Evonik, Probiotics International Limited (Protexin), UAS Laboratories LLC., Lallemand, Glac Biotech, Ab-Biotics, Winclove Probiotics, Sacco System, General Mills Inc., ADM, Unique Biotech Ltd, Lifeway Foods, Inc., Suja Life, Llc, Biohm Health, Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
